APA (7th ed.) Citation

Allegretti, J. R., Cheifetz, A. S., Dulai, P. S., Stevens, A., Chapas-Reed, J., Chesnel, L., . . . Gupta, R. (2025). Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial. American Journal of Gastroenterology (Lippincott Williams & Wilkins), 120(7), 1624. https://doi.org/10.14309/ajg.0000000000003269

Chicago Style (17th ed.) Citation

Allegretti, Jessica R., et al. "Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial." American Journal of Gastroenterology (Lippincott Williams & Wilkins) 120, no. 7 (2025): 1624. https://doi.org/10.14309/ajg.0000000000003269.

MLA (9th ed.) Citation

Allegretti, Jessica R., et al. "Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial." American Journal of Gastroenterology (Lippincott Williams & Wilkins), vol. 120, no. 7, 2025, p. 1624, https://doi.org/10.14309/ajg.0000000000003269.